Immage Biotherapeutics Beta vs. Number Of Employees
Based on Immage Biotherapeutics' profitability indicators, Immage Biotherapeutics Corp may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Immage Biotherapeutics' ability to earn profits and add value for shareholders.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please note, there is a significant difference between Immage Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immage Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immage Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For Immage Biotherapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Immage Biotherapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Immage Biotherapeutics Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Immage Biotherapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Immage Biotherapeutics Corp over time as well as its relative position and ranking within its peers.
Immage |
Immage Biotherapeutics Number Of Employees vs. Beta Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Immage Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Immage Biotherapeutics value to that of its competitors to determine the firm's financial worth. Immage Biotherapeutics Corp is currently regarded as number one stock in beta category among its peers. It is rated below average in number of employees category among its peers creating about 0.05 of Number Of Employees per Beta. The ratio of Beta to Number Of Employees for Immage Biotherapeutics Corp is roughly 18.71 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Immage Biotherapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Immage Number Of Employees vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Immage Biotherapeutics |
| = | 56.14 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Immage Biotherapeutics |
| = | 3 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Beta Analysis
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immage Biotherapeutics will likely underperform.
Immage Biotherapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Immage Biotherapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Immage Biotherapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Immage Biotherapeutics' change in net profit over the period of time. It can combine multiple indicators of Immage Biotherapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Immage Biotherapeutics Corp. does not have significant business operations. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited. IMMAGE BIOTHERAPEUTICS is traded on OTC Exchange in the United States.
Immage Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Immage Biotherapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Immage Biotherapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Immage Biotherapeutics' important profitability drivers and their relationship over time.
Use Immage Biotherapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immage Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immage Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Immage Biotherapeutics Pair Trading
Immage Biotherapeutics Corp Pair Trading Analysis
The ability to find closely correlated positions to Immage Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immage Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immage Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immage Biotherapeutics Corp to buy it.
The correlation of Immage Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immage Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immage Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immage Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Immage Biotherapeutics position
In addition to having Immage Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Measuring and Control Equipment Thematic Idea Now
Measuring and Control Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Measuring and Control Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Measuring and Control Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |